0286418-A1 is referenced by 21 patents and cites 3 patents.

The present invention provides a method for preventing or treating disease caused by retroviruses, particularly human immunodeficiency virus. Liposomes are prepared containing phosphorylated derivatives of nucleosides which act as chain-terminators of viral DNA. The phosphorylated nucleosides per se, without encapsulation in liposomes, do not readily enter cells. However, they are found to be effective if encapsulated in liposomes because they remain in liposomes longer, they do not escape easily from cells, and they constitute the active form for incorporation in viral DNA chains. When administered to a host, the liposomes are taken up by endocytic and phagocytic cells, which are important reservoirs of HIV infection.; If coated with an appropriate ligand, such as an immunoglobulin molecule, liposomes containing the phosphorylated nucleosides can be directed to phagocytic cells, CD4-positive cells, or infected host cells.

Anti-retroviral agents and delivery systems for the same.
Application Number
EP19880303144 19880408
Publication Number
0286418 (A1)
Application Date
April 8, 1988
Publication Date
October 12, 1988
Weinstein John N
Us Commerce
A61K 31/70
A61K 09/50
C07H 19/00
A61P 43/00
A61P 31/00
A61K 47/48
A61K 31/7042
A61K 31/70
A61K 09/127
C12N 09/99
C07H 19/20
C07H 19/10
A61P 43/00
A61P 31/12
A61K 47/48
A61K 31/708
A61K 31/7076
A61K 31/7072
A61K 31/7068
A61K 31/7064
A61K 31/7052
A61K 31/7042
A61K 31/70
A61K 09/127
C12N 09/99
View Original Source Download PDF